Results 181 to 190 of about 127,955 (302)

Findings from the DUMA program: internet access, and frequency and nature of use among police detainees [PDF]

open access: yes
Examining access to and the extent of engagement with the Internet in illicit drug-using populations may provide an indication of the extent to which the online illicit drug market is usurping the physical illicit drug market, according to this report ...
Eileen Patterson, Susan Goldsmid
core  

A Case Study and Review of the Literature on IgA Nephropathy in Crohn's Disease

open access: yesClinical Case Reports, Volume 14, Issue 4, April 2026.
ABSTRACT IgA nephropathy (IgAN) is the most frequently reported glomerular disease associated with inflammatory bowel disease (IBD), particularly Crohn's disease (CD), although pediatric cases remain rare. We report IgAN in a 16‐year‐old male with CD following intestinal surgery and during long‐term infliximab therapy, with renal impairment occurring ...
Giovanna Fernanda Vazzana   +6 more
wiley   +1 more source

A Challenging Presentation of Mycoplasma pneumoniae: Mild Hepatic Dysfunction With Persistent Leukocytosis in a Pediatric Patient

open access: yesClinical Case Reports, Volume 14, Issue 4, April 2026.
ABSTRACT Mycoplasma pneumoniae (MP) is a common pediatric respiratory pathogen that can rarely present with extrapulmonary manifestations such as hepatic involvement. Recognition of hepatic dysfunction in this context is important for accurate diagnosis and timely therapy.
Robert J. Heins   +2 more
wiley   +1 more source

Misclassification of Diabetes Mellitus in Resource‐Limited Settings: A Case Study and Clinical Review

open access: yesClinical Case Reports, Volume 14, Issue 4, April 2026.
ABSTRACT Recent refinements to diabetes classification frameworks have inadvertently complicated the diagnostic process, particularly in resource‐limited settings. This case demonstrates that meticulous phenotyping, judicious selection of feasible investigations, and disciplined clinical inference are essential to avoid misclassification and deliver ...
Issakwisa Mwakyula   +2 more
wiley   +1 more source

Single‐Dose Bioequivalence Study of Elagolix Tablets 200 mg (Test Product) and Elagolix Tablets 200 mg (Reference Product) in Healthy Non‐Pregnant, Non‐Lactating Premenopausal Female Subjects Under Fasting Conditions

open access: yesClinical Pharmacology in Drug Development, Volume 15, Issue 4, April 2026.
Abstract Elagolix is a short‐acting oral gonadotropin‐releasing hormone antagonist utilized for treating endometriosis‐associated pain by rapidly suppressing gonadotropins and estradiol. Although well characterized in Western populations, clinical data regarding its use in Indian women remain limited.
Sudershan Kumar   +6 more
wiley   +1 more source

Home - About - Disclaimer - Privacy